Article
Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients…
Therapeutics and Clinical Risk Management · 2018 · Hu CC, Weng CH, Chang LC, Lin CL, Chen YT, Hu CF, Hua MC, Chen LW, Chien RN
Key facts
| Title | Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy |
|---|---|
| First author | Hu CC, Weng CH, Chang LC, Lin CL, Chen YT, Hu CF, Hua MC, Chen LW, Chien RN |
| Journal | Therapeutics and Clinical Risk Management |
| Published | Apr 30, 2018 |
| DOI | 10.2147/TCRM.S158424 |
| Devices mentioned | K022339, K040761, K060574, K061249, K150510, K934312, K934384, K934410, K934517, K934544, K935373, K935374 and 48 more |
| Product codes mentioned | CDD, CDP, CDX, CEC, CFT, CGJ, CIG, CIT, DBF, DIO, DIS, DJG and 38 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1